PON1 and familial hyperaldosteronism: The contribution of PON1 in CVD is minor in healthy populations but it is known that genotypes with minor effects in general population may have more pronounced effects in patients, for example in FH cases (Leus et al., 2001; Wiegman et al., 2004).